






Total Synthesis of Dictyodendrin B 
 
Alois Fürstner,* Mathias M. Domostoj, and Bodo Scheiper 




General: All reactions were carried out in flame-dried glassware under Ar. The solvents used 
were purified by distillation over the drying agents indicated and were transferred under Ar: 
THF, Et2O, DME (Mg-anthracene), CH2Cl2 (P4O10), MeCN, Et3N (CaH2), MeOH (Mg), DMF 
(Desmodur, dibutyltin dilaurate), hexane, toluene (Na/K). Flash chromatography: Merck 
silica gel 60 (230-400 mesh). IR: Nicolet FT-7199 spectrometer, wavenumbers (ν~ ) in cm−1. 
MS (EI): Finnigan MAT 8200 (70 eV), ESI-MS: Finnigan MAT 95, accurate mass 
determinations: Bruker APEX III FT-MS (7 T magnet). Melting points: Büchi melting point 
apparatus B-540 (corrected). Elemental analyses: H. Kolbe, Mülheim/Ruhr. All commercially 
available compounds (Fluka, Lancaster, Aldrich) were used as received. 
 
NMR: Spectra were recorded on a Bruker DPX 300, AV 400, or DMX 600 spectrometer in 
the solvents indicated; chemical shifts (δ) are given in ppm relative to TMS, coupling 
constants (J) in Hz. The solvent signals were used as references and the chemical shifts 
converted to the TMS scale (CDCl3: δC ≡ 77.0 ppm; residual CHCl3 in CDCl3: δH ≡ 7.26 ppm; 
CD2Cl2: δC ≡ 53.8 ppm; residual CH2Cl2 in CD2Cl2: δH ≡ 5.32 ppm; residual CHD2OD in 
CD3OD: δH ≡ 3.31 ppm; CD3OD: δC ≡ 49.0 ppm). The coupling constants were not averaged. 
The proton spectra of the para-disubstituted phenyl groups are of AA’XX’ spin systems. The 
splitting of signals of greatest intensity is quoted as the value of the coupling constant 3J(AX), 
assuming that 5J(AX’) is zero. Where indicated, the signal assignments are unambiguous; the 
numbering scheme is arbitrary and is shown in the inserts. The assignments are based upon 
 S-2 
1D and 2D spectra recorded using the following pulse sequences from the Bruker standard 
pulse program library: DEPT; COSY (cosygs and cosydqtp); HSQC (invietgssi) optimized for 
1J(C,H) = 145 Hz; HMBC (inv4gslplrnd) for correlations via nJ(C,H); HSQC-TOCSY 
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Scheme S-1. Conditions: [a] (i) NaH, DMF, 2h; (ii) dimethyl sulfate, DMF, 67%; [b] NaOH, 
MeOH/H2O (2:1), 87%; [c] oxalyl chloride, DMF cat., CH2Cl2, quant. 
 
 
Methyl 2-methoxy-3-(4-methoxyphenyl)-2-propenoate (S-2).1 To a suspension of NaH 
(1.60 g, 66.6 mmol) in dry DMF (15 mL) was added a solution of 4-hydroxyphenylpyruvic 
acid (2.00 g, 11.1 mmol) in dry DMF (10 mL) at 0°C. The reaction mixture was allowed to 
warm to ambient temperature and stirred for 2 h. Dimethyl sulfate (8.35 mL, 88.8 mmol) was 
then added and the mixture was stirred for another 2 h. After completion of the reaction, water 
was introduced, the aqueous layer was extracted with EtOAc (3 x 20 mL), the combined 
organic layers were washed with water and dried (Na2SO4). Evaporation of the solvent 
followed by flash chromatography of the residue (EtOAc/hexanes, 1:4) afforded the title 
compound S-2 as a pale yellow oil (1.66 g, 67%). 1H NMR (300 MHz, CD2Cl2): δ = 7.72 (d, J 
= 8.9 Hz, 2 H), 6.94 (s, 1 H), 6.91 (d, J = 8.9 Hz, 2 H), 3.82 (s, 3 H), 3.81 (s, 3 H), 3.75 (s, 3 
H); 13C NMR (75 MHz, CDCl3): δ = 165.2, 160.6, 144.3, 132.1, 126.5, 124.0, 114.3, 59.3, 
55.6, 52.2; IR (film): ν~ = 3001, 2952, 2910, 2841, 1717, 1634, 1605, 1571, 1511, 1437, 1354, 
1315, 1301, 1252, 1175, 1102, 1030, 834, 552, 521 cm-1; MS (EI): m/z (%): 222 (100 [M]+), 
179 (52), 151 (53), 120 (18), 91 (14), 77 (16), 59 (9), 51 (11); HRMS (EI) calcd. for 
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 Kotsuki, H.; Saito, I.; Matsuura, T. Tetrahedron Lett. 1981, 22, 469-472. 
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C12H14O3: 222.0892; found: 222.0894. The stereochemical assignment of the configuration of 
the double bond is tentative.  
 
2-Methoxy-3-(4-methoxyphenyl)-2-propenoic acid (S-3). A solution of compound S-2 (246 
mg, 1.19 mmol) in MeOH (2.4 mL) and aq. NaOH (2 M, 1.2 mL) was stirred at ambient 
temperature for 2 h. For work up, the solution was acidified with aq. HCl (1 M) and the 
product was extracted with CH2Cl2 (3 x 10 mL). The combined organic layers were dried 
(Na2SO4) and evaporated, and the residue was dried under high vacuum for several hours to 
afford the title acid S-3 (216 mg, 87 %) as a white solid. mp = 168-169°C. 1H NMR (300 
MHz, CD3OD): δ = 7.70 (d, J = 8.9 Hz, 2 H), 6.98 (s, 1 H), 6.91 (d, J = 8.9 Hz, 2 H), 3.02 (s, 
3 H), 3.72 (s, 3 H); 13C NMR (75 MHz, CD3OD): δ = 167.8, 161.8, 145.3, 132.8, 127.4, 
125.2, 115.1, 59.3, 55.7; IR (film): ν~ = 3000, 2975, 2938, 2837, 2515, 1684, 1603, 1569, 
1509, 1443, 1425, 1249, 1175, 929, 822 cm-1; MS (EI): m/z (%): 208 (100 [M]+), 165 (36), 
148 (18), 137 (20), 121 (14), 91 (11), 77 (18), 63 (6), 51 (11); HRMS (EI) calcd. for 
C11H12O4: 208.0735; found: 208.0733. The stereochemical assignment of the configuration of 
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 Conditions: [a] 2-bromopropane, K2CO3, DMF, 100°C, 99%; [b] p-MeOC6H4CHO, NaOMe, MeOH, 
70°C, 74%; [c] (i) TosMIC, NaH, THF, −30°C; (ii) p-MeOC6H4(CH2)2Br, reflux, 83%; [d] Fe powder, 
aq. HCl, EtOH, 96%; [e] 10, CH2Cl2, Et3N, DMAP cat., 89%; [f] TiCl3/2 KC8, DME, pyridine, reflux, 
71-93%; [g] hν, MeCN, Pd/C cat., C6H5NO2, 81%; [h] NBS, THF, 0°C, 69%; [i] (i) MeLi, THF, 
−78°C; (ii) n-BuLi, −78°C; (iii) p-MeOC6H4CHO, −78°C→rt, 97%; [j] TPAP (10%), NMO, MS 4Å, 
CH2Cl2 (0.01 M), 66% (17), 16% (16); [k] BCl3, CH2Cl2, −20°C, 85%; [l] Cl3CCH2OSO2Cl, DABCO, 
CH2Cl2, 92%; [m] (i) BCl3, TBAI, CH2Cl2, 0°C→rt; (ii) Zn, HCOONH4, MeOH, 58%. 
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3-Hydroxy-2-nitrophenylethanone (5).2 3-Hydroxyacetophenone (10.0 g, 73.4 mmol) was 
dissolved in ice-cold concentrated H2SO4 (30 mL). The resulting solution was cooled to 
−20°C before a mixture of concentrated H2SO4 (4 mL) and HNO3 (5 mL) was slowly added 
over 15 min. Once the addition was complete, the mixture was stirred for another 10 min 
before it was carefully poured on ice. After stirring for another 30 min, the yellow precipitate 
was filtered off and recrystallized twice from ethanol to yield compound 5 as a beige solid 
(3.81 g, 29 %). mp = 134-135°C; 1H NMR (300 MHz, CDCl3): δ = 10.5 (s, 1 H), 7.60 (dd, J = 
8.5, 7.4 Hz, 1 H), 7.22 (dd, J = 8.5, 1.3 Hz, 1 H), 6.84 (dd, J = 7.4, 1.3 Hz, 1 H), 2.52 (s, 3 H); 
13C NMR (75 MHz, CDCl3): δ = 199.4, 155.1, 140.6, 137.0, 121.1, 118.1, 30.3; IR (film): ν~   
3093, 1666, 1582, 1530, 1472, 1376, 1290, 798 cm-1; MS (EI): m/z (%): 181 (48 [M]+), 166 
(100), 139 (13), 92 (36), 77 (8), 66 (24), 43 (97), 39 (35). 
 
3-Isopropoxy-2-nitrophenylethanone (6). A suspension of ketone 5 (1.00 g, 5.52 mmol), 
isopropyl bromide (0.64 mL, 6.79 mmol) and K2CO3 (2.67 g, 19 mmol) in DMF (12 mL) was 
stirred at 100 °C for 3 h. For work up, water (80 mL) was added, the aqueous layer was 
extracted with tert-butyl methyl ether (3 x 20 mL), the combined organic layers were washed 
with water (5 x 20 mL) and aq. NaOH (2 M, 20 mL) before they were dried (Na2SO4) and 
evaporated, thus affording the title compound 6 as brown syrup which solidified upon 
standing at ambient temperature (1.22 g, 99%). 1H NMR (300 MHz, CDCl3): δ = 7.49 (m, 1 
H), 7.35 (m, 1 H), 7.24 (m, 1 H), 4.65 (hept, J = 6.1 Hz, 1 H), 2.57 (s, 3 H), 1.35 (d, J = 
6.1 Hz, 6 H); 13C NMR (75 MHz, CDCl3): δ = 195.5, 150.0, 131.5, 130.8, 120.7, 119.4, 73.2, 
27.9, 21.7; IR (film): ν~  = 3090, 2982, 2935, 1697, 1579, 1544, 1446, 1375, 1286, 1106, 949, 
851, 790 cm-1; MS (EI): m/z (%): 223 (8 [M]+), 181 (30), 166 (100), 139 (9), 92 (8), 77 (3), 66 
(8), 51 (3), 43 (63), 39 (11); HRMS (EI) calcd. for C11H13NO4 (M): 223.0844; found: 
223.0846. 
 
(2E)-3-Isopropoxy-2-nitrophenyl-3-(4-methoxyphenyl)-2-propenone (7). Sodium (294 
mg, 12.8 mmol) was dissolved in MeOH (10 mL) before a solution of p-
methoxybenzaldehyde (6.20 mL, 51.1 mmol) and ketone 6 (5.70 g, 25.6 mmol) in MeOH (10 
mL) was added. The mixture was stirred at 70 °C for 2 h before it was slowly cooled to 
ambient temperature. The resulting precipitate was filtered off, washed successively with 
water (20 mL) and MeOH (20 mL), and dried under high vacuum to give chalcone 7 as a 
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 Butenandt, A.; Hallmann, G.; Beckmann, R. Chem. Ber. 1957, 90, 1120-1124. 
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white solid (6.44 g, 74 %). mp = 111-112°C (MeOH); 1H NMR (400 MHz, CDCl3): δ = 7.57 
(d, J = 15.9 Hz, 1 H), 7.54-7.47 (m, 3 H), 7.26-7.20 (m, 2 H), 6.99 (d, J = 15.9 Hz, 1 H), 6.91 
(m, 2 H), 4.67 (hept, J = 6.1 Hz, 1 H), 3.85 (s, 3 H), 1.37 (d, J = 6.1 Hz, 6 H); 13C NMR 
(100 MHz, CDCl3): δ = 189.6, 162.2, 150.1, 147.0, 134.3, 131.1, 130.6, 126.9, 121.4, 120.2, 
118.1, 114.5, 73.1, 55.4, 21.8; IR (film): ν~ = 2980, 2935, 2839, 1664, 1642, 1589, 1572, 
1541, 1512, 1466, 1444, 1424, 1374, 1259, 1174, 1029, 977, 830, 799 cm-1; MS (EI): m/z 
(%): 341 (14 [M]+), 188 (23), 176 (8), 163 (55), 149 (38), 135 (38), 121 (100), 107 (17), 90 
(9), 77 (11), 63 (3), 43 (18). HRMS (EI) calcd. for C19H19NNaO5 (M+Na): 364.1160; found: 
364.1157. 
 
2-Bromoethyl-4-methoxybenzene.3 A mixture of 2-(methoxyphenyl)ethanol (18.2 g, 119 
mmol) and PBr3 (3.74 mL, 39.8 mmol) in toluene was refluxed for 2 h before it was allowed 
to cool to ambient temperature. The organic phase was washed with sat. aq. 
Na2S2O3/NaHCO3 (1:1, 3 x 20 mL) and dried (Na2SO4) before the solvent was evaporated to 
give the title bromide as a colorless liquid (24.3 g, 95 %). 1H NMR (300 MHz, CDCl3): δ = 
7.11 (d, J = 8.6 Hz, 2 H), 6.84 (d, J = 8.6 Hz, 2 H), 3.78 (s, 3 H), 3.51 (t, J = 7.6 Hz, 2 H), 
3.08 (t, J = 7.6 Hz, 2 H); 13C NMR (75 MHz, CDCl3): δ = 158.5, 130.9, 129.6, 113.9, 55.2, 
38.5, 33.3; IR (film): ν~ = 3031, 3002, 2957, 2935, 2908, 2834, 1611, 1584, 1513, 1464, 1441, 
1302, 1247, 1179, 1035, 821 cm-1; MS (EI): m/z (%): 216 (16), 214 (17 [M]+), 135 (19), 121 




pyrrol-3-yl}methanone (8). To a stirred suspension of NaH (2.11 g, 87.9 mmol) in dry THF 
(60 mL) was added a solution of TosMIC (5.70 g, 29.3 mmol) and chalcone 7 (5.00 g, 14.7 
mmol) in THF (40 mL) at –30°C. The mixture was stirred at –30 °C for 1 h and at ambient 
temperature for 2 h. After completion of the reaction, 2-bromoethyl-4-methoxybenzene (15.8 
g, 73.3 mmol) was introduced and the solution was refluxed for 2 h. For work up, the reaction 
was quenched with water (20 mL) and the product was extracted with EtOAc (3 x 20 mL). 
The combined organic layers were washed with brine and dried over Na2SO4. Evaporation of 
the solvent followed by flash chromatography of the residue (EtOAc/hexanes, 1:3) afforded 
pyrrole 8 as a pale yellow foam (6.27 g, 83 %). mp = 68-69°C; 1H NMR (400 MHz, CDCl3): 
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δ = 7.33 (m, 2 H), 7.25 (t, J = 8.0 Hz, 1 H), 7.05 (m, 1 H), 6.97 (m, 2 H), 6.88 (dd, J = 1.0, 
7.6 Hz, 1 H), 6.84-6.78 (m, 5 H), 6.56 (m, 1 H), 4.61 (hep, J = 6.1 Hz, 1 H), 4.01 (t, J = 
7.0 Hz, 2 H), 3.78 (s, 3 H), 3.77 (s, 3 H), 2.98 (t, J = 7.0 Hz, 2 H), 1.34 (d, J = 6.1 Hz, 6 H); 
13C NMR (100 MHz, CDCl3): δ = 186.4, 158.6, 158.4, 149.7, 141.0, 136.1, 130.7, 130.5, 
129.9, 129.7, 129.5, 127.1, 126.7, 121.5, 121.2, 120.7, 117.3, 114.1, 113.3, 73.0, 55.2, 55.2, 
52.0, 36.8, 21.8; IR (film): ν~ = 3124, 2979, 2935, 2836, 1643, 1611, 1537, 1514, 1465, 1443, 
1383, 1288, 1247, 1179, 1034, 833 cm-1; MS (EI): m/z (%): 514 (100 [M]+), 322 (23), 160 
(10), 135 (48), 121 (41), 105 (9), 77 (4), 43 (6); HRMS (EI) calcd. for C30H30N2NaO6 
(M+Na): 537.2001; found: 537.1997. 
 
(2-Amino-3-isopropoxyphenyl){4-(4-methoxyphenyl)-1-[2-(4-methoxyphenyl)ethyl]1H-
pyrrol-3-yl}methanone (9). Aq. HCl (0.6 M, 21 mL, 12.5 mmol) was added to a suspension 
of compound 8 (4.67 g, 9.08 mmol) and iron powder (5.07 g, 90.8 mmol) in EtOH (90 mL) 
and the resulting suspension was refluxed for 2 h with vigorous stirring. The mixture was 
cooled to ambient temperature and filtered through a pad of Celite, the filtrate was diluted 
with EtOAc (200 mL) and successively washed with sat. aq. NaHCO3 (50 mL) and brine (30 
mL). Drying of the organic layer over Na2SO4 followed by evaporation of the solvent gave 
aniline 9 as a yellow foam (4.24 g, 96 %). mp = 54-55°C; 1H NMR (300 MHz, CDCl3): δ = 
7.29 (m, 2 H), 7.13 (dd, J = 1.2, 8.1 Hz, 1 H), 6.98 (m, 2 H), 6.86-6.81 (m, 5 H), 6.72 (d, 
J = 2.3 Hz, 1 H), 6.64 (d, J = 2.3 Hz, 1 H), 6.43 (m, 1 H), 6.02 (s, 2 H), 4.51 (hept, J = 6.1 Hz, 
1 H), 4.03 (t, J = 7.0 Hz, 2 H), 3.78 (s, 3 H), 3.77 (s, 3 H), 2.98 (t, J = 7.0 Hz, 2 H), 1.35 (d, 
J = 6.1 Hz, 6 H); 13C NMR (75 MHz, CDCl3): δ = 193.3, 158.5, 158.0, 144.9, 141.7, 129.7, 
129.6, 129.2, 128.4, 127.5, 126.7, 125.3, 122.0, 120.8, 120.0, 115.5, 114.0, 113.6, 113.5, 70.9, 
55.2, 55.1, 51.7, 37.0, 22.1; IR (film): ν~ = 3488, 3358, 3119, 3034, 2975, 2933, 2834, 1612, 
1541, 1513, 1454, 1385, 1246, 1220, 1036, 833 cm-1; MS (EI): m/z (%): 484 (69 [M]+), 441 
(10), 363 (100), 321 (42), 186 (15), 135 (23); HRMS (EI) calcd. for C30H33N2O4 (M+H): 






Table S-1. Tabular survey of the NMR data of amine 9 recorded 
in CD2Cl2. All assignments are unambiguous, cf. General; 





Position δC [ppm] (150 MHz) δH [ppm] (600 MHz) 
1 120.5 6.68 (d, J = 2.3 Hz, 1H) 
2 126.7  
3 122.4  
4 128.6 6.72 (d, J = 2.3 Hz, 1H) 
5 52.1 4.08 (t, J = 7.0 Hz, 2H) 
6 37.3 3.02 (t, J = 7.0 Hz, 2H) 
7 130.4  
8 130.1 7.04 (m, 2H) 
9 114.4 6.86 (m, 2H) 
10 159.0  
11 55.5 3.794 (s, 3H) 
12 128.2  
13 129.6 7.27 (m, 2H) 
14 113.7 6.83 (m, 2H) 
15 158.5  
16 55.5 3.792 (s, 3H) 
17 193.5  
18 121.2  
19 142.1  
20 145.4  
21 116.0 6.87 (m, 1H) 
22 114.0 6.46 (m, 1H) 
23 125.7 7.13 (dd, J = 1.2, 8.1 Hz, 1H) 
24 71.5 4.55 (sep, J = 6.1 Hz, 1H) 
25 22.3 1.36 (d, J = 6.1 Hz, 6H) 































yl}carbonyl)phenyl]-2-methoxy-3-(4-methoxyphenyl)-2-propenamide (11). Freshly 
distilled oxalyl chloride (0.70 mL, 8.26 mmol) was added dropwise to a suspension of acid 
S−3 (1.29 g, 6.19 mmol) in CH2Cl2 (20 mL) at 0 °C under argon, followed by 4 drops of dry 
DMF. After 5 min, the cooling bath was removed and the mixture was stirred at ambient 
temperature for 1 h. The solvent was evaporated and the residue was dried in vacuo.  
The crude acid chloride 10 thus formed was dissolved in CH2Cl2 (10 mL) and the resulting 
solution was added dropwise to a stirred solution containing aniline 9 (2.00 g, 4.13 mmol), 
freshly distilled Et3N (2.90 mL, 20.7 mmol) and DMAP (50 mg, 0.619 mmol) in CH2Cl2 (20 
mL) at ambient temperature. The mixture was stirred for 30 min before it was quenched with 
sat. aq. NaHCO3 (5 mL). The layers were separated, the organic phase was washed 
successively with aq. HCl (3 M, 10 mL), sat. aq. NaHCO3 (10 mL) and brine (5 mL) before it 
was dried over MgSO4. Evaporation of the solvent followed by flash chromatography of the 
residue (EtOAc/hexanes, 3:7 → 1:1) afforded amide 11 as a yellow foam (2.49 g, 89 %). mp 
= 69-70°C; 1H NMR (300 MHz, CDCl3): δ = 8.61 (s, 1 H), 7.61 (m, 2 H), 7.37 (m, 2 H), 7.08 
(m, 1H), 7.00-6.94 (m, 6 H), 6.88-6.78 (m, 6 H), 6.54 (m, 1 H), 4.55 (hept, J = 6.1 Hz, 1 H), 
4.00 (t, J = 7.1 Hz, 2 H), 3.81 (s, 3 H), 3.77 (s, 6 H), 3.66 (s, 3 H), 2.98 (t, J = 7.1 Hz, 2 H), 
1.34 (d, J = 6.1 Hz, 6 H); 13C NMR (75 MHz, CDCl3): δ = 190.0, 162.1, 159.7, 158.5, 158.1, 
151.4, 147.4, 137.6, 131.4, 131.0, 129.8, 129.7, 127.4, 126.8, 126.2, 125.3, 124.5, 121.8, 
121.3, 120.8, 120.2, 115.2, 114.0, 114.0, 113.2, 71.1, 59.2, 55.2, 51.8, 36.9, 22.1; IR (KBr): 
ν~ = 3406, 3122, 2974, 2935, 2836, 1683, 1638, 1604, 1512, 1465, 1442, 1247, 1147, 1032, 
851, 833, 785 cm-1; MS (EI): m/z (%): 674 (51 [M]+), 630 (8), 469 (12), 334 (40), 308 (16), 
162 (17), 148 (100), 121 (22), 120 (18), 105 (8); HRMS (EI) calcd. for C41H42N2NaO7 
(M+Na) 697.2889; found: 697.2886.  
 
7-Isopropoxy-2-[methoxy-2-(4-methoxyphenyl)ethenyl]-3-{4-(4-methoxyphenyl)-1-[2-(4-
methoxyphenyl)ethyl]-1H-pyrrol-3-yl}-1H-indole (12). Dry DME (40 mL) was carefully 
added (exothermic!) to a mixture of TiCl3 (2.85 g, 18.5 mmol) and C8K (4.96 g, 36.7 mmol) at 
0 °C under argon and the resulting suspension was refluxed for 1.5 h. Dry pyridine (1.5 mL, 
18.5 mmol) was introduced and reflux was continued for another 15 min. A solution of 
ketoamide 11 (2.49 g, 3.69 mmol) in dry DME (10 mL) was then introduced and the mixture 
was refluxed until TLC indicated complete conversion of the substrate (ca. 1.5 h). After 
reaching ambient temperature, the mixture was filtered through a plug of Celite layered on 
silica, which was carefully rinsed with EtOAc/PhMe (1:1, 150 mL), and the combined 
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filtrates were concentrated in vacuo. Purification of the residue by flash chromatography 
(EtOAc/hexanes, 1:6 + 1% 6 M NH3/MeOH) yielded indole 12 as a yellow oil (1.68 g, 71 %). 
The yield was raised to 93% when this reaction was performed on a somewhat smaller scale 
(278 mg of ketoamide 11). 1H NMR (300 MHz, CD2Cl2): δ = 8.55 (s, 1 H), 7.35 (m, 2 H), 
7.08-7.02 (m, 4 H), 6.97-6.90 (m, 2 H), 6.82-6.76 (m, 5 H), 6.67-6.57 (m, 4 H), 5.93 (m, 1 H), 
4.75 (hep, J = 6.1 Hz, 1 H), 4.15 (t, J = 7.0 Hz, 2 H), 3.79 (s, 3 H), 3.73 (s, 3 H), 3.64 (s, 3 H), 
3.34 (s, 3 H), 3.08 (t, J = 7.0 Hz, 2 H), 1.44 (d, J = 6.1 Hz, 6 H); 13C NMR (75 MHz, CDCl3): 
δ = 158.8, 158.6, 157.9, 147.3, 144.4, 132.1, 131.1, 130.9, 130.2, 130.1, 129.8, 128.8, 128.3, 
126.9, 124.6, 121.9, 120.4, 118.9, 114.5, 114.2, 113.9, 113.7, 112.7, 105.0, 70.8, 58.5, 55.5, 
55.4, 52.0, 37.7, 22.5; IR (KBr): ν~ = 3480, 3429, 2974, 2933, 2834, 1609, 1575, 1547, 1511, 
1463, 1454, 1441, 1248, 1177, 1034, 832, 784 cm-1; MS (EI): m/z (%): 642 (44 [M]+), 627 




dihydro-pyrrolo[2,3-c]carbazole (13). In a water-cooled photoreactor, a solution of indole 
12 (450 mg, 0.70 mmol) and nitrobenzene (1 mL) in MeCN (140 mL) was purged with argon 
for 30 min. After that time, Pd/C (10% w/w, 370 mg, 0.350 mmol) was added and the 
resulting suspension was irradiated with a medium pressure Hg-lamp (Hanovia, 250 W) 
(cooled by a stream of cold water) for 2.5 h. After completion of the reaction, the suspension 
was filtered through a silica/Celite pad, which was carefully rinsed with EtOAc/PhMe (1:1, 
100 mL). The filtrate was evaporated and the residue was purified by flash chromatography 
(EtOAc/hexanes, 1:6) to afford pyrrolocarbazole 13 as a yellow solid (365 mg, 81 %). mp = 
173-174 °C; 1H NMR (400 MHz, CD2Cl2) δ = 8.54 (br s, 1 H), 7.53 (d, J = 8.8 Hz, 2 H), 7.41 
(d, J = 8.8 Hz, 2 H), 7.09 (d, J = 8.8 Hz, 2 H), 7.01 (d, J = 8.8 Hz, 2 H), 6.90 (s, 1 H), 6.79 (d, 
J = 7.6 Hz, 1 H), 6.73 (dd, J = 8.0, 7.6 Hz, 1 H), 6.72 (d, J = 8.8 Hz, 2 H), 6.66 (d, J = 8.8 Hz, 
2 H), 6.23 (d, J = 7.6 Hz, 1 H), 4.76 (hept, J = 6.0 Hz, 1 H), 3.93 (s, 3 H), 3.92 (s, 3 H), 3.84 
(m, 2 H), 3.74 (s, 3 H), 3.66 (s, 3 H), 2.63 (m, 2 H), 1.45 (d, J = 6.0 Hz, 6 H); 13C NMR (100 
MHz, CD2Cl2) δ = 159.6, 159.1, 158.4, 143.7, 140.6, 132.4, 132.0, 130.7, 130.6, 130.3, 129.8, 
129.1, 128.9, 127.8, 124.9, 119.4, 118.7, 118.1, 117.1, 117.0, 115.2, 113.8, 113.7, 113.4, 
106.9, 70.9, 61.4, 55.5, 55.3, 50.2, 37.0, 22.2; IR (film) ν~ = 3328, 2935, 2831, 1614, 1572, 
1544, 1513, 1455, 1436, 1404, 1369, 1340, 1304, 1276, 1236, 1174, 1135, 1117, 1038, 1024, 
1004, 931, 913, 874, 859, 834, 819, 783, 770, 734, 678 cm-1. MS (EI): m/z (%): 484 (69 




ethyl]-3,6-dihydropyrrolo[2,3-c]carbazole (14). NBS (230 mg, 1.29 mmol) was added in 
one portion to a stirred solution of the pyrrolocarbazole 13 (830 mg, 1.29 mmol) in THF (26 
mL) at 0°C. After stirring for 30 min, the cooling bath was removed and the solution was 
allowed to reach ambient temperature over 10 min. The mixture was concentrated under 
reduced pressure to ca. 1/5 of the original volume and passed through a silica pad, which was 
rinsed with EtOAc/hexanes (1:2). The combined filtrates were evaporated and the solid thus 
obtained was recrystallized from hot EtOAc/hexanes to give the title compound 14 as an off-
white solid (639 mg, 69%). The compound should be stored in a refrigerator to avoid 
migration of the bromine along the periphery of the heteroarene system. mp = 201-202 °C 
(decomp.); 1H NMR (400 MHz, CD2Cl2): δ = 8.54 (s, 1 H), 7.54 (d, J = 8.6 Hz, 2 H), 7.41 (d, 
J = 8.6 Hz, 2 H), 7.10 (d, J = 8.1 Hz, 2 H), 7.08 (d, J = 8.1 Hz, 2 H), 6.77 (d, J = 7.7 Hz, 1 H), 
6.72 (br s, 4 H), 6.67 (t, J = 8.0 Hz, 1 H), 5.85 (d, J = 8.1 Hz, 1 H), 4.74 (hept, J = 6.1 Hz, 1 
H), 3.99 (m, 2 H), 3.95 (s, 3 H), 3.93 (s, 3 H), 3.75 (s, 3 H), 3.65 (s, 3 H), 2.58 (m, 2 H), 1.43 
(d, J = 6.1 Hz, 6 H); 13C NMR (100 MHz, CD2Cl2) δ = 160.0, 159.9, 158.8, 144.0, 141.0, 
133.3, 132.7, 131.1, 130.6, 130.1, 129.8, 129.6, 127.8, 124.9, 120.2, 119.2, 118.3, 118.1, 
116.7, 114.9, 114.4, 114.2, 114.1, 114.0, 107.4, 71.2, 61.6, 55.8, 55.8, 55.6, 48.7, 36.0, 22.5; 
IR (film): ν~ = 3353, 2932, 2831, 1613, 1573, 1547, 1511, 1498, 1455, 1440, 1408, 1356, 
1338, 1317, 1302, 1285, 1244, 1170, 1141, 1123, 1104, 1027, 1007, 933, 916, 862, 840, 820, 
786, 753, 740, 686, 659 cm-1 ; MS (EI): m/z (%): 722 (10), 721 (42), 720 (100 [M+]), 719 
(43), 718 (93), 556 (14), 554 (13), 541 (12), 539 (11), 518 (10), 461 (8), 135 (56); HRMS 
(ESI+) calcd. for C41H39Br1N2O5Na (M+Na): 741.1940; found: 741.1937. 
 
{7-Isopropoxy-5-methoxy-1,4-bis-(4-methoxyphenyl)-3-[2-(4-methoxyphenyl)ethyl]-3,6-
dihydropyrrolo[2,3-c]carbazol-2-yl}-(4-methoxyphenyl)methanol (15). MeLi (1.6 M in 
Et2O, 0.59 mL, 0.946 mmol) was added dropwise to a stirred solution of the bromo-
pyrrolocarbazole 14 (619 mg, 0.860 mmol) in dry THF (33 mL) at –78 °C under argon. After 
stirring for 15 min, n-BuLi (1.6 M in hexanes, 0.59 mL, 0.946 mmol) was added dropwise and 
stirring was continued for another 15 min before a solution of p-methoxybenzaldehyde (0.26 
mL, 2.15 mmol) in dry THF (1 mL) was slowly introduced. After 15 min, the cooling bath 
was removed and the mixture was allowed to reach ambient temperature over 30 min. For 
work up, the reaction was carefully quenched with aq. NH4Cl (1 mL) and brine (1 mL), the 
organic layer was dried (MgSO4) and evaporated, and the residue was purified by flash 
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chromatography (EtOAc/hexanes, 1:4) to furnish compound 15 as a white foam (647 mg, 97 
%). 1H NMR (400 MHz, CD2Cl2): δ = 8.58 (s, 1 H), 7.54-7.45 (m, 4 H), 7.29 (d, J = 8.8 Hz, 2 
H), 7.07-7.02 (m, 3 H), 6.98 (dd, J = 8.4, 2.8 Hz, 1 H), 6.84 (d, J = 8.8 Hz, 2 H), 6.78 (d, J = 
7.6 Hz, 1 H), 6.69 (dd, J = 8.0, 8.0 Hz, 1 H), 6.60 (d, J = 8.8 Hz, 2 H), 6.31 (d, J = 8.8 Hz, 2 
H), 6.03 (d, J = 2.8 Hz, 1 H), 5.80 (d, J = 8.0 Hz, 1 H), 4.76 (hept, J = 6.4 Hz, 1 H), 3.92 (s, 3 
H), 3.87 (s, 3 H), 3.82 (m, 2 H), 3.77 (s, 3 H), 3.74 (s, 3 H), 3.57 (s, 3 H), 2.54 (m, 1 H), 2.46 
(d, J = 3.7 Hz, 1 H), 2.09 (m, 1 H), 1.45 (dd, J = 6.1, 1.4 Hz, 6 H); 13C NMR (100 MHz, 
CD2Cl2) δ =159.9, 159.8, 159.1, 158.4, 144.0, 141.4, 137.8, 134.8, 133.6, 133.5, 133.1, 133.0, 
131.1, 130.2, 129.9, 129.5, 129.5, 127.9, 127.1, 125.1, 120.3, 119.2, 118.4, 118.4, 116.8, 
115.7, 114.3, 114.1, 114.1, 113.9, 113.8, 113.6, 114.3, 114.1, 114.1, 113.9, 113.8, 113.6, 
107.3, 71.2, 68.0, 61.3, 55.9, 55.8, 55.6, 55.5, 47.6, 36.0, 22.5; IR (film): ν~ = 3451, 2969, 
2934, 2835, 1729, 1610, 1573, 1547, 1510, 1463, 1440, 1402, 1371, 1318, 1301, 1284, 1240, 
1171, 1106, 1064, 1030, 1007, 953, 918, 875, 837, 804, 789, 770, 734, 709, 677 cm-1; MS 
(EI): m/z (%): 778 (10), 777 (34), 776 (66 [M+]), 655 (12), 626 (14), 612 (9), 534 (7), 506 
(16), 449 (7), 135 (63), 134 (44), 121 (100), 119 (19), 91 (15), 65 (8); HRMS (ESI+) calcd. 
for C49H48N2O7Na (M+Na): 799.3359; found: 799.3352. 
 
{7-Isopropoxy-5-methoxy-1,4-bis-(4-methoxyphenyl)-3-[2-(4-methoxyphenyl)ethyl]-3,6-
dihydropyrrolo[2,3-c]carbazol-2-yl}-(4-methoxyphenyl) methanone (17). TPAP (9.1 mg, 
0.026 mmol) was added to a suspension of alcohol 15 (202 mg, 0.260 mmol), NMO (61.0 mg, 
0.520 mmol) and activated molecular sieves (4Å, 600 mg) in dry CH2Cl2 under argon. The 
mixture was vigorously stirred for 2 h before it was filtered through a pad of Celite and the 
filtrate was evaporated. Purification of the residue by flash chromatography (EtOAc/hexanes, 
1:4) afforded ketone 17 as a yellow foam (129 mg, 66 %). 1H NMR (400 MHz, CD2Cl2): δ = 
8.68 (s, 1 H), 7.59 (d, J = 8.8 Hz, 2 H), 7.57 (d, J = 8.8 Hz, 2 H), 7.27 (d, J = 8.4 Hz, 2 H), 
7.10 (d, J = 8.4 Hz, 2 H), 6.80 (d, J = 8.4 Hz, 2 H), 6.77 (d, J = 7.6 Hz, 1 H), 6.71 (d, J = 8.8 
Hz, 2 H), 6.66 (dd, J = 8.4, 8.4 Hz, 1 H), 6.62 (d, J = 8.8 Hz, 2 H), 6.54 (d, J = 8.4 Hz, 2 H), 
5.81 (d, J = 8.0 Hz, 1 H), 4.76 (hept, J = 6.0 Hz, 1 H), 3.96 (m, 2 H), 3.92 (s, 3 H), 3.82 (s, 3 
H), 3.79 (s, 3 H), 3.70 (s, 3 H), 3.68 (s, 3 H), 2.55 (m, 2 H), 1.45 (d, J = 6.0 Hz, 6 H); 13C 
NMR (100 MHz, CD2Cl2) δ = 189.7, 163.3, 159.7, 159.2, 158.3, 143.8, 143.0, 136.3, 133.2, 
132.4, 132.3, 131.8, 131.2, 130.8, 130.5, 129.7, 129.6, 128.8, 127.4, 124.6, 121.8, 119.5, 
118.9, 118.2, 116.9, 115.7, 113.9, 113.6, 113.3, 113.3, 107.0, 70.9, 61.3, 55.5, 55.5, 55.5, 
55.2, 47.6, 36.7, 22.2; IR (film): ν~ = 3344, 2969, 1934, 1835, 1596, 1572, 1533, 1510, 1462, 
1439, 1420, 1384, 1371, 1350, 1316, 1285, 1239, 1170, 1153, 1106, 1063, 1028, 1008, 971, 
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932, 922, 905, 869, 836, 795, 781, 773, 733, 704 cm-1; MS (EI): m/z (%): 775 (32), 774 (58 
[M+]), 654 (15), 653 (33), 640 (14), 595 (16), 135 (100), 121 (25); HRMS (ESI+) calcd. for 
C49H47N2O7 (M+H): 775.3370; found: 775.3378. 
 
{7-Hydroxy-5-methoxy-1,4-bis-(4-methoxyphenyl)-3-[2-(4-methoxyphenyl)ethyl]-3,6-
dihydropyrrolo[2,3-c]carbazol-2-yl}-(4-methoxyphenyl)methanone (18). BCl3 (1 M in 
heptanes, 1.32 mL, 1.32 mmol) was added dropwise to a stirred solution of compound 15 (256 
mg, 0.330 mmol) in CH2Cl2 (16 mL) at –20 °C. After 1 h the reaction was quenched at that 
temperature with sat. aq. NaHCO3 (3 mL) with vigorous stirring and the mixture was allowed 
to warm to ambient temperature over 30 min. The organic layer was washed with brine (3 
mL), dried over Na2SO4 and evaporated, and the residue was purified by flash 
chromatography (EtOAc/hexanes, 2:3) to afford compound 18 as a yellow oil (206 mg, 85 %). 
1H NMR (400 MHz, CD2Cl2): δ = 8.68 (s, 1 H), 7.58 (d, J = 8.8 Hz, 2 H), 7.56 (d, J = 8.8 Hz, 
2 H), 7.25 (d, J = 8.4 Hz, 2 H), 7.05 (d, J = 8.4 Hz, 2 H), 6.78 (d, J = 8.4 Hz, 2 H), 6.70 (d, J 
= 8.8 Hz, 2 H), 6.69 (d, J = 7.2 Hz, 1 H), 6.60 (d, J = 8.8 Hz, 2 H), 6.58 (t, J = 8.0 Hz, 1 H), 
6.52 (d, J = 8.8 Hz, 2 H), 5.81 (d, J = 8.0 Hz, 1 H), 5.25 (s, 1 H), 3.96 (m, 2 H), 3.91 (s, 3 H), 
3.80 (s, 3 H), 3.78 (s, 3 H), 3.69 (s, 3 H), 3.65 (s, 3 H), 2.52 (m, 2 H); 13C NMR (100 MHz, 
CD2Cl2) δ = 190.3, 163.7, 159.9, 159.5, 158.6, 143.4, 141.6, 136.6, 133.5, 132.7, 132.6, 
132.0, 131.8, 131.5, 130.8, 130.4, 129.9, 129.3, 129.0, 127.6, 125.6, 122.6, 119.9, 119.3, 
118.7, 117.6, 116.0, 114.2, 113.9, 113.6, 109.561.5, 55.8, 55.8, 55.8, 55.5, 64.4, 47.9, 36.9; IR 
(film): ν~ = 3359, 2935, 1609, 1595, 1577, 1532, 1512, 1463, 1438, 1422, 1287, 1245, 1174, 
1107, 1067, 1034, 966, 835 cm-1; MS (EI): m/z (%): 733 (15), 732 (30 [M+]), 612 (10), 611 
(25), 598 (17), 135 (100), 121 (29), 105 (7); HRMS (ESI+) calcd. for C46H41N2O7 (M+H): 
733.2913; found: 733.2908.  
 
Sulfuric acid 5-methoxy-2-(4-methoxybenzoyl)-1,4-bis-(4-methoxyphenyl)-3-[2-(4-
methoxyphenyl)ethyl]-3,6-dihydropyrrolo[2,3-c]carbazol-7-yl ester 2,2,2-trichloroethyl 
ester (19). A solution of 2,2,2-trichloroethyl chlorosulfate (91 mg, 0.37 mmol) in CH2Cl2 
(1 mL) was added in one portion to a stirred solution of phenol 18 (180 mg, 0.243 mmol) and 
DABCO (83 mg, 0.37 mmol) in CH2Cl2 (24 mL) at ambient temperature. After completion of 
the reaction (2 h), sat. aq. NH4Cl (4 mL) was added, the layers were separated, and the 
organic layer was washed with brine (2 mL) before being dried over Na2SO4. Evaporation of 
the solvent followed by flash chromatography of the residue (EtOAc/hexanes, 1:3) gave 
compound 19 as a yellow foam (214 mg, 92 %). 1H NMR (400 MHz, CD2Cl2): δ = 8.82 (s, 1 
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H), 7.58 (d, J = 8.8 Hz, 2 H), 7.57 (d, J = 8.8 Hz, 2 H), 7.30 (dd, J = 8.0, 0.6 Hz, 1 H), 7.26 
(d, J = 8.4 Hz, 2 H), 7.11 (d, J = 8.8 Hz, 2 H), 6.81 (d, J = 8.8 Hz, 2 H), 6.77 (dd, J = 8.4, 8.0 
Hz, 1 H), 6.71 (d, J = 8.8 Hz, 2 H), 6.61 (d, J = 8.8 Hz, 2 H), 6.52 (d, J = 8.8 Hz, 2 H), 6.19 
(d, J = 8.4 Hz, 1 H), 4.85 (s, 2 H), 3.95 (m, 2 H), 3.91 (s, 3 H), 3.81 (s, 3 H), 3.79 (s, 3 H), 
3.69 (s, 3 H), 3.65 (s, 3 H), 2.53 (m, 2 H); 13C NMR (100 MHz, CD2Cl2) δ = 189.9, 163.8, 
160.1, 159.7, 142.9, 137.0, 135.2, 133.5, 132.6, 131.9, 131.8, 131.1, 130.6, 129.9, 128.7, 
127.6, 127.2, 124.7, 121.7, 120.0, 119.6, 119.1, 116.3, 115.4, 114.3, 113.9, 113.8, 113.7, 81.3, 
61.7, 55.8, 55.8, 55.8, 55.5, 48.0, 37.0; IR (film): ν~ = 2935, 2835, 1597, 1572, 1533, 1511, 
1462, 1442, 1417, 1351, 1311, 1286, 1243, 1193, 1173, 1158, 1106, 1068, 1030, 996, 965, 
926, 885, 867, 836, 812, 794, 782, 770, 724 cm-1; HRMS (ESI+) calcd. for C48H42Cl3N2O10S1 
(M+H): 943.1622; found: 943.1622.  
 
Dictyodendrin B (1). BCl3 (1 M in heptanes, 0.76 mL, 0.76 mmol) was added dropwise to a 
stirred solution of compound 19 (60 mg, 0.064 mmol) and (n-Bu)4NI (282 mg, 0.0764 mmol) 
in CH2Cl2 (6.4 mL) at 0 °C under argon. The cooling bath was removed and the solution was 
stirred at ambient temperature for 1.5 h. The reaction was quenched with water (10 mL) and 
the resulting mixture was vigorously stirred for 1 h before it was diluted with EtOAc (20 mL). 
The organic layer was successively washed with sat. aq. Na2SO3 (5 mL) and brine (2 mL) 
before it was dried over Na2SO4 and evaporated. The residue was passed through a pad of 
reverse-phase chromatography gel (LiChroprep RP-18, E. Merck, Darmstadt, 5 g), eluting 
with 3:1 MeOH/H2O, and the product thus obtained was immediately processed in the next 
step without further characterization.  
To a solution of this crude material and HCO2NH4 (24 mg, 0.38 mmol) in dry MeOH (6.4 
mL) was added activated zinc (8.3 mg, 0.13 mmol). The suspension was vigorously stirred for 
1 h before excess zinc was filtered off through a pad of Celite. The filtrate was evaporated and 
the residue purified by flash chromatography (CH2Cl2/MeOH, 9:1 → 4:1). The pooled 
fractions were concentrated, and the residue was dissolved in water (1 mL). 4 Drops of 
ammonia (7 M in MeOH) were added, and the product was lyophilized to afford 
dicytodendrin B 1 (28 mg, 58% over both steps) as a yellow foam. 1H NMR (600 MHz, 
CD3OD): δ = 8.48 (s, 1 H), 7.44 (d, J = 8.4 Hz, 2 H), 7.34 (d, J = 9.0 Hz, 2 H), 7.18 (d, J = 
7.8, 1.2 Hz, 1 H); 7.05 (d, J = 8.4 Hz, 2 H), 7.03 (d, J = 8.4 Hz, 2 H), 6.65 (d, J = 9.0 Hz, 2 
H), 6.57 (dd, J = 7.8, 7.8 Hz, 1 H), 6.56 (d, J = 9.0 Hz, 2 H), 6.47 (d, J = 9.0 Hz, 2 H), 6.41 
(d, J = 8.4 Hz, 2 H), 6.02 (dd, J = 8.4, 0.6 Hz, 1 H), 3.96 (t, J = 7.2 Hz, 2 H), 2.47 (t, J = 7.2 
Hz, 2 H); 13C NMR (150 MHz, CD3OD) δ = 192.0, 163.1, 158.7, 157.7, 156.8, 141.7, 138.8, 
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136.2, 134.3, 134.3, 134.0, 133.8, 132.0, 130.6, 129.3, 129.2, 127.1, 126.8, 125.8, 122.7, 
118.9, 118.2, 117.2, 116.8, 116.1, 116.0, 115.6, 112.6, 48.4, 37.7; IR (film): ν~ = 3250, 1673, 
1593, 1535, 1513, 1441, 1369, 1325, 1204, 1157, 1104, 1053, 1004, 921, 838, 798, 764, 724, 
679 cm-1. MS (ESI-) m/z: 741 [M - H]; HRMS (ESI-) calcd. for C41H29N2O10S1 (M-H): 
741.1549; found: 741.1549. 
 
2,2,2-Trichloroacetyl chlorosulfate.4 SO2Cl2 (5.0 mL, 62 mmol) was added dropwise to a 
stirred solution of 2,2,2-trichloroethanol (6.0 mL, 62 mmol) and pyridine (5.0 mL, 62 mmol) 
in Et2O (120 mL) at –20 °C. Once the addition was complete, the mixture was warmed to 
ambient temperature, and stirring was continued for 1 h. For work up, the reaction was 
carefully quenched with water (20 mL), the layers were separated, and the organic layer was 
dried (MgSO4) and evaporated. The crude product thus obtained was purified by distillation, 
yielding the title compound as a colorless oil (10.6 g, 69 %, bp = 38 °C/0.04 mbar). 1H NMR 
(400 MHz, CDCl3): δ = 4.92 (s, 2 H); 13C NMR (100 MHz, CDCl3): 91.3, 81.2; IR (film): ν~   
3021, 2963, 1420, 1376, 1193, 1088, 1045, 993, 875, 780, 729, 597 cm-1; MS (EI): m/z (%): 
213 (35), 129 (100), 119 (43), 117 (44), 99 (23), 77 (12), 61 (12), 49 (14), 29 (12). 
 
7-Hydroxy-1,4-bis(4-hydroxyphenyl)-3-[2-(4-hydroxyphenyl)ethyl]pyrrolo[2,3-c]-
carbazol-2,5(3H,6H)-dione (20). A solution of BBr3 (1 M in CH2Cl2, 0.31 mL, 0.31 mmol) is 
added to a solution of compound 13 (20 mg, 0.031 mmol) and cyclohexene (0.063 mL, 0.620 
mmol) in CH2Cl2 (8 mL) at −78°C and the resulting mixture is allowed to slowly reach 
ambient temperature over the course of 8 h. The reaction is quenched with aq. KHSO4 (10% 
w/w, 2 mL) and NaOH (20% w/w, 1 mL) and the organic phase is washed with water. The 
aqueous phase is acidified with conc. HCl (2 mL) and extracted with tert-butyl methyl ether, 
the combined organic layers are washed with brine, dried over Na2SO4 and evaporated. 
Purification of the residue by preparative reverse-phase HPLC (Nucleodur 100-16-C-18/A, 
MeOH/H2O) afforded the compound 20 as a green-brown solid (8.5 mg, 49%). 1H NMR (600 
MHz, d6-acetone): δ = 7.40 (m, 2 H), 7.32 (m, 2H), 6.98 (m, 2 H), 6.96 (m, 2 H), 6.68 (m, 2 
H), 6.66 (dd, J = 7.8, 1.1 Hz, 1 H), 6.63 (t, J = 7.8 Hz, 1 H), 6.62 (m, 2 H), 5.95 (dd, J = 7.8, 
1.1 Hz, 1 H), 3.45 (m, 2 H), 2.43 (m, 2 H); 13C NMR (150 MHz, d6-acetone): δ = 179.4, 
171.8, 159.5, 158.5, 156.7, 149.6, 145.5, 134.8, 133.7, 133.3, 133.1, 130.6, 129.8, 129.8, 
129.3, 126.2, 124.4, 123.9, 122.8, 118.1, 116.2, 115.9, 115.8, 115.6, 113.4, 110.2, 43.7, 34.6. 
                                                
4
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IR (film): ν~ = 3312, 2925, 1687, 1582, 1511, 1436, 1392, 1357, 1217, 1168, 1106, 1080, 827, 
780 cm-1. MS (EI): m/z (%): 557 ([M+H]). HRMS (EI) calcd. for C34H24N2NaO6: 579.15321 
(M+Na); found: 579.15271 (M+Na). 
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